Brief: Orbimed Advisors Llc Reports 8.4% Stake In Sionna Therapeutics As Of Feb 10 - SEC Filing
Sionna Therapeutics Inc SION.O :
* ORBIMED ADVISORS LLC REPORTS 8.4% STAKE IN SIONNA
THERAPEUTICS
AS OF FEB 10 - SEC FILING
Source text: ID:
Further company coverage: SION.O
Recent news on Sionna Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
U.S. STOCKS ON THE MOVE-Microsoft, Coastal Financial, Eli Lilly
U.S. STOCKS ON THE MOVE-Microsoft, Coastal Financial
Sionna hits record low after experimental drug misses mid-stage trial goal
Vertex Pharma rises after rival genetic disorder drug setback